2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry.

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Acute Coronary Syndromes ePosters Pharmacotherapy ESC Premium Access ESC Congress 2020